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Introduction
Testicular germ cell cancer (TGCC) is the most
common malignancy in the 20–40 year-old age
group. Although the survival rates are excellent,
disseminated TGCC can have a lethal outcome.
Furthermore, the intensive treatment of metastas-
ing cancer disease by chemotherapy is associated
with a number of side effects. These problems can
be avoided if the malignant disease is diagnosed 
at an early stage, ideally at the carcinoma-in-situ
(CIS) stage. In searching for proper diagnostic
methods for early detection of TGCC, ultrasound
has is put forward as a possible option. This review
aims to summarize the current clinical knowledge
in relation to possibilities and limitations in use of
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ultrasonic examination as an instrument in diagnos-
ing testicular malignancy at an early, pre-invasive
stage.
Prevalence of Testis Cancer and
Geographical Distribution
Although not being among the most prevalent
malignancies TGCC is the most common cancer
disease in males aged 20 to 40 years. The epidemi-
ology of TGCC has some peculiarities which point
to the impact of environmental and lifestyle related
factors, but additionally is suggestive of genetics,
in relation to the aetiology of this disease.
During the past five to six decades a steady in-
crease in the incidence of TGCC has been observed
world-wide [1,2]. The oldest reliable register data
origin from Denmark where a nationwide cancer
register has been established since 1943. In this
country the incidence of TGCC is now 4–5 times
higher than it was in the 1940s. This increase is not
due to improvement in the diagnostic procedures.
Untreated TGCC is lethal and in this age group
such an outcome will lead to an investigation of
possible causes. Furthermore, the external position
of the testis makes this organ easy to investigate
and the risk of overlooking a tumor is negligible.
Interestingly Denmark leads the world in the inci-
dence of TGCC, for the past few years being accom-
panied by Norway [1]. In these countries the life
time risk of TGCC is about 1%. The reason why this
malignancy is much more common now than it was
few decades ago is unknown. It has also not been
explained why there is a huge discrepancy in the
incidence of TGCC between populations which
geographically, socially and genetically are very
closely related. Thus the risk of TGCC is twice as
high in Denmark as compared to Sweden and five
times higher than in Finland. Interestingly, despite
these geographical differences, the rate of increase
in the incidence has been similar in all Caucasians
populations from which reliable data are available.
These epidemiological features point to the impact
of environmental and/or lifestyle related factors in
the aetiology of TGCC [3] and it is now strongly
believed that these factors are affecting the devel-
oping testis in early foetal life [4]. These assump-
tions are strengthened by finding that the risk of
TGCC in the first generation of immigrants are
close to that in the country of origin, whereas 
in the second generation, the risk of TGCC is at 
the level of the country where these subjects are
living [5–7].
However, genetic factors also seem to play a
role. The risk of TGCC is significantly lower in Afro-
Americans as compared to Caucasians living in the
USA. Furthermore, sons and brothers of TGCC
patients have an increased risk of developing this
malignancy [8]. Thus, the available epidemiologi-
cal data point to the impact of genetic as well as
environmental and/or lifestyle related factors in
the aetiology of TGCC.
Carcinoma-in-situ Testis
In 1972 Skakkebæk reported on two cases of TGCC
preceded by the presence of intra-tubular atypical
testicular cells, which he called CIS cells [9]. These
cells possessed many of the cytological character-
istics of malignancy, including large and irregular
nuclei, multiple mitoses and glycogen rich cyto-
plasm (Fig. 1). Their migration to the interstitial
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Fig. 1. Carcinoma-in-situ (CIS) of the testis. Hematoxylin and
eosin staining. Note the malignant characteristics of CIS cells—
large and irregular nucleus and abundant cytoplasm. Apart from
the CIS cells, Sertoli cells (SC) are the only cell type present
within the tubules.
testicular space and to rete testis represented his-
tological evidence of their invasive potential [10]. 
It is now evident that both seminomatous and
non-seminomatous germ cell cancers, except the
spermatocytic seminoma, are preceded by the stage
of CIS [11]. Although conclusive evidence has not
yet been provided, it seems probable that most, if
not all cases of CIS progress into the invasive stage
of TGCC. Thus follow up cases of CIS found in infer-
tile men and in the contralateral testis of patients
with unilateral TGCC have shown that at least 70%
of these men develop invasive cancer in 7 years [12].
In cases where multiple biopsies were performed
over time, in untreated cases the disappearance of
CIS has never been reported. The might indicate
that all cases, CIS sooner or later develops into
invasive cancers. 
Epidemiological data, morphological and molec-
ular studies have pointed to early foetal life as the
time that the CIS cells form [11,13]. These cells
seem to be closely related to the foetal germ cells
and following malignant transformation, remain
dormant until the post-pubertal period when, whilst
probably under the influence of sex steroids and/or
gonadotropins, they start to proliferate and to dif-
ferentiate into seminoma or non-seminoma [14]. 
Diagnosed at the stage of CIS, TGCC can easily
be prevented. In unilateral cases, simple orchidec-
tomy is curative. In bilateral cases, or if the CIS is
found in the contralateral testis of a patients with
unilateral TGCC, castration can be avoided by giv-
ing a localized fractionated irradiation of 16–18Gy to
the CIS bearing gonad. This therapy can prevent the
development of cancer in the testis in question [15].
The fact that TGCC is preceded by the CIS
stage which has a foetal origin, and with a very
high probability of developing into a cancer which
can be prevented if the malignancy is diagnosed 
at the pre-invasive stage, makes CIS a very attrac-
tive target for early screening for testicular malig-
nancy. Although the results of TGCC treatment are
excellent, it should be kept in mind that a few
cases of the disease affecting young males may
have a lethal outcome. Furthermore, radiotherapy
and chemotherapy, which can be avoided if the
disease is diagnosed at CIS stage, may have serious
long term effects including infertility and even an
increase of metabolic syndrome or cardiovascular
diseases [16].
Testicular Biopsy and Potential 
Markers for Diagnosing CIS 
The biological features of testicular CIS makes it an
attractive target for early diagnosis and, thereby,
prevention of TGCC. If the method for diagnosing
CIS is highly sensitive, one single test performed in
young adulthood should be enough to exclude
the risk of developing testicular cancer [17]. How-
ever so far no large screening programmes for this
condition have yet been established. The reason is
a lack of proper screening methods. 
Due to the relatively low incidence of TGCC,
even in high risk populations such as Denmark and
Norway, the method of diagnosing CIS needs not
only to be highly sensitive but also very specific.
Furthermore, the method should preferably be
non-invasive and relatively cheap, if not to be
applied only to high risk groups. 
Despite the fact that several CIS tissue markers
have been reported [13,17], screening for CIS by
performing blood tests has not proven successful.
Another option is to look for CIS cells in the ejacu-
late, since they, like normal germ cells, are supposed
to be released from the lumen of the seminiferous
tubules into the semen [17–19]. During the past
more than 20 years, attempts have been made to
develop a reliable method for detection of CIS germ
cells in semen, by use of flow cytometry [20], in situ
hybridization [21] and cytochemistry [18,19]. The
last technique seems to be the most successful, but
although some progress in the development of an
assay for diagnosing CIS by semen analysis has
been made, this method is not ready for clinical
application [13]. 
The standard method for reliable detection of CIS
is open testicular biopsy, followed by examination
of a hematoxylin-eosin (Fig. 1) and/or immunohis-
tochemically stained tissue sample (Fig. 2) [22].
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When examined by a trained pathologist, the
specificity of diagnosing CIS by histological exami-
nation of testicular tissue is 100%. Even the sensi-
tivity of detecting CIS seems to be rather high. Thus,
it was shown that a single biopsy will detect CIS in
approximately 91% of cases when CIS is present in
the testis [23]. It has, additionally, been suggested
that the number of false negative results may be re-
duced by performing two-site biopsy and/or the use
of specific immunohistochemical markers [23,24]. 
These favorable figures apply for an open sur-
gical biopsy. CIS cells have been found in a needle
and fine needle biopsy, but the diagnostic accuracy
of these tests has not yet been investigated [25].
Although testicular biopsy appears to be a reliable
tool in diagnosing CIS, the invasive nature of this
technique makes it improper for large scale screen-
ing. Additionally the use of biopsy is today limited
to high risk patients, such as those having unilateral
TGCC, or selected groups of men with a history of
cryptorchidism and/or infertility problems. 
Ultrasound as a Potential Screening
Method for CIS
Ultrasound was brought into focus due to its 
non-invasiveness and the relatively accessibility of
the necessary equipment. Furthermore, ultrasound
scanning is painless and safe. As case studies high-
lighted echogenic differences in some patients with
early malignancies, ultrasound scanning came into
focus in the early eighties as a possible tool in diag-
nosing CIS [26]. It was especially clear that some
testes showed bright echogenic points on ultra-
sound, and this phenomenon was later named
microcalcifications or microlithiais (Fig. 3). The
presence of microcalcifications has been partly con-
firmed by mammographic technique [27]. Micro-
lithiasis can to some extent be correlated to
calcified bodies in the tubules histologically [28,29]
(Fig. 4). Microlithiasis is part of the abnormal
echopattern dealt with in this review.
The Echopattern in Non Selected Men
The echopattern in non selected men has been
assessed in prospective studies. We studied 287 men
appearing for the medical board prior to medical
service and 157 men employed in an industrial
company [30]. The dominant echopattern was re-
gular or slightly irregular as seen in 68% of the
testes (Fig. 5). A moderately irregular pattern was
seen in 28% (Fig. 6), and only 4% of the testes
showed a very irregular pattern (Fig. 7) or a pattern
with bright echogenic points (Fig. 8). In our stud-
ies a testis with microlithiasis was registered as very
CIS Testis and Ultrasound
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Fig. 2. CIS immunohistochemically stained with the monoclonal
antibody M2A. Tubules with CIS cells are diffusely spread all
over the testis.
Fig. 3. Microlithiasis of the testis visualized by ultrasound. The
testis is the round structure filling the upper half of the picture.
The testes contains innumerable bright (white) echogenic points.
The delineation of the testis is not sharp. This correlates with 
a soft testis, which is a sign of low sperm quality.
irregular if more than two echogenic points were
seen per testis. 
Peterson et al [31] has also studied men from 
a military training group. The scanned 1,504 men
and found a prevalence of 5% for microlithiasis.
Microlithiasis was defined as the presence of more
than five high intensive signals per testis. The pat-
tern was nominated scant when 5–25 signals were
seen in the testis, moderate when more than 25
were seen, and too numerous to count.
von Eckardstein et al [32] studied 198 healthy
men with normal sperm count. The authors dis-
cerned between less than five echogenic foci per
picture, and more than five foci per picture. Three
men had a low degree and three had a higher
degree. A total of six men had microlithiasis corre-
sponding to a prevalence of 3%.
The presence of microlithiasis in an asymptoma-
tic group of men has been studied by Serter et al
[33] in a prospective study of 2,179 army trainees.
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Fig. 4. Testicular tissue with intratubular calicifications
(arrows). The calcium bodies are seen inside tubules with nor-
mal spermatogenic tissue in this case. This type of microcalcifi-
cation is more frequently found in testes with carcinoma-in-situ
but even in maldescended gonads and those from infertile men.
The association between testicular microlithiasis is possible but
not well established. 
Fig. 5. Ultrasound print of a transverse scan of normal testis
with a slightly irregular echopattern. The testis is measured
between calipers and the rete testis marked by a blue arrow.
This is a normal finding by ultrasound.
Fig. 6. Ultrasound print of longitudinal scan of a testis with a
moderately irregular echopattern. This echopattern correlates
with reduced sperm quality. The number 3 indicates a score of
3 in the scale of 1 to 4 in irregularity. The bright irregular 
linings below the testis represents hair and air over the skin of
the thigh.
Fig. 7. Ultrasound print of the testis from a patient with pre-
vious parotitis which has destroyed the germinative epithelium.
The echopattern is very irregular. The inserted Doppler square
shows low perfusion and there is no suspicion of cancer.
The prevalence of microlithiasis in one or both
testes was 2.4%.
Microlithiasis is thus a rare finding in non selected
men. The prevalence is between 2.4% and 5%,
depending on the definition. Microlithiasis is fur-
thermore more prevalent than testicular malignancy
even in countries like Denmark and Norway where
men have a high lifetime risk of TGCC. The inclu-
sion of a very irregular echopattern [30] does not
seem to increase the prevalence.
The Echopattern in Infertile Men 
An overview of studies in infertile men is given in
Table 1. We studied 95 infertile men by ultrasound
and bilateral open biopsies. They were selected if
their sperm count <20 million/mL and if they ful-
filled at least one of following criteria; history of
maldescensus or orchidometer volume less than
15 mL; or if their sperm count <10 million/mL [34].
The median echopattern was significantly more
irregular than in the non selected group. The “very
irregular pattern” group in our studies included
microlithiasis with more than two echogenic foci per
testis, but also otherwise severe irregularity of the
echopattern. A very irregular echopattern was found
in 29% of the testes. None of the biopsies showed
CIS. The degree of irregularity was negatively 
CIS Testis and Ultrasound
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Fig. 8. Ultrasound print of a longitudinal scan of a testis with
numerous bright echogenic points. The pattern of microlithiasis
is not as uniformly distributed as in Fig. 3. The pattern is most
intense in the upper and in the lower pole of the testis.
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correlated to spermatogenesis and positively cor-
related to the number of obliterated tubules.
Gouveia-Brazao et al [35] retrospectively studied
the association between microlithiasis and CIS in 263
subfertile men. Sperm count was not given in the
article. All men were examined by ultrasound and
bilateral biopsies. Microlithiasis was defined as five
or more hyperechoic foci per transducer field. Fifty
three men (20%) had testicular microlithiasis. Twenty
three men displayed the pattern in one testis and
30 in both. None of the patients with unilateral
microlithiasis had CIS in their biopsies; in contrast,
20% with bilateral microlithiasis were diagnosed
with CIS. There was one case diagnosed with CIS
among 210 men without microlithiasis (0.5%).
Aizenstein et al [36] studied consecutive infer-
tile patients and found a prevalence of microlith-
iasis of 2.8% when defining microlithiasis by more
than five echogenic foci per transducer field in
either testis. No testicular biopsies were done.
Thomas et al [37] studied 159 consecutive infer-
tile men and found a prevalence for microlithiasis
of 6.2%. Microlithiasis was noted if more than five
hyperechogenic foci were seen per transducer field.
Five had the echopattern in a minimal degree and
five in a marked degree.
von Eckardstein et al [32] also studied infertile
men by ultrasound. They found the same preva-
lence of microlithiasis as in their group of normal
men, namely 3%. Testicular biopsy was performed
in 76 out of 1,399 infertile men, and CIS was de-
tected in two, both being atrophic testes with mi-
crolithiasis. In one of these patients biopsy had been
performed 5 years earlier without revealing CIS.
The prevalence of microlithiasis in infertile men
is between 2.8% and 29%, probably depending on
the definition of infertility and of co-existing diag-
noses, and also depending on the definition con-
cerning the degrees of microlithiasis (Table 1). When
biopsies were taken, CIS was diagnosed in groups
with microlithiasis but very rarely in groups without
microlithiasis (0.5%) [35]. The highest prevalence of
microlithiasis in infertile men was found by Lenz et al
[34] but the authors included testes with a very
irregular pattern in the group with microlithiasis.
The Echopattern in Cryptorchid Men 
There is a correlation between microlithiasis and a
history of cryptorchidism [35]. We have performed
a prospective study of men with a history of cryp-
torchidism [26]. These men were contacted years
after being admitted for cryptorchidism and offered
ultrasound of the testes and biopsy of the previously
registered maldescended testes. A total of 192 men
agreed to have ultrasound and biopsy. Ultrasound
was performed of previously non-descended testes.
A very irregular pattern or a pattern with micro-
lithiasis was seen in 12 testes (3.2%) of which two
testes had descended normally. These two testes
were also biopsied. CIS was diagnosed in two testes,
both being from the group with a very irregular
echopattern. One case of CIS was in one of the
normally descended testes which was selected for
biopsy due to the ultrasonic pattern. CIS was thus
diagnosed in 17% of testes with a very irregular
echopattern. The low rate of irregularity in this
early study might be explained by the use of a
3.5 MHz probe with near-field focus. The resolu-
tion was, thus, not optimal, only higher degrees of
irregularity being disclosed. It was the first, prospec-
tive study on echopatterns of the testes and CIS,
and the results looked promising leading to more
prospective studies on the testicular echopattern.
The risk of CIS in this study of cryptorchid men
was 17% for the group with a very irregular ultra-
sonic pattern.
The Echopattern in the Contralateral
Testis in Men with Testicular Cancer 
The prevalence of CIS in the contralateral testes 
in men with unilateral testicular cancer seems to
be 5%–8% [38–40]. We performed a prospective
study of the contralateral testis in men with unilat-
eral testicular cancer [41]. Seventy-eight men had
testicular biopsy and ultrasound scanning of the
contralateral testis. A very irregular pattern was seen
in 50% of the testes. Eight of these were diagnosed
with CIS (21%) and a total of nine testes were
CIS Testis and Ultrasound
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diagnosed with CIS (12%). The last case of CIS was
in a testis with a less irregular pattern, and in this
testis CIS was only seen in <10% of the tubules in
the biopsy.
von Eckardstein et al [32] studied 83 men with
unilateral testicular cancer using ultrasound of the
contralateral testis. Twenty two (27%) had micro-
calcifications. Most (14) had more than five per
scanning field and the remaining eight had less than
five microcalcifications per scanning field. Biopsy
data were not given in the article.
Holm et al [39] scanned the contralateral testis
in 64 men with unilateral testicular cancer and found
microcalcifications in nine testes, seven of which
harboured CIS, one with early invasive cancer. Six
testes with CIS were registered as showing a more
regular echopattern. The 78% prevalence of CIS in
testes with microcalcifications in this study seems
very high. The prevalence of CIS in testes with a nor-
mal echopatterns in this study might indicate that
the criteria for classifying the ultrasound pattern
might differ from those applied by other researchers.
Evaluation of echopatterns vary between stud-
ies and the prevalence of an irregular pattern or a
pattern with microcalcificatios differs accordingly.
The risk of CIS in the contralateral testis seems to
be 21%–27% for an abnormal echopattern if the
study by Holm et al is excluded.
The Echopattern Adjacent to 
a Testicular Cancer
As CIS is the precursor of germ cell tumors CIS
must be present close to a tumor. It is therefore of
interest to look at the echopattern in testes where
a testes residue is present. In a prospective study
56 patients were scanned the evening before sur-
gery due to a suspicion of testicular tumors [43].
The ultrasound examination showed tumor or tu-
mor suspicion in 35 cases, and surgery confirmed
the diagnosis in 31 cases. The result of ultrasound
was not disclosed to the surgeon. There was no
cancer in the group where ultrasound did not indi-
cate presence of a tumor. In 24 testis cancer cases
the tumor was so small that the echopattern of 
the testis residue of the affected testis could be
evaluated. In all cases a very irregular pattern was
seen.
Risk of Testis Cancer in Non-selected
Patients with Microlithiasis
An overview of publications correlating the risk of
malignancy in non-selected patients with microlith-
iasis is given in Table 2.
Backus et al [43] retrospectively analyzed 42 con-
secutive patients with microlithiasis. These patients
were admitted for a variable number of scrotal dis-
eases. The number of echogenic foci varied from 
five to 60 per ultrasound image. Thirteen patients
displayed an area of hypoechogenecity and a
tumor was confirmed in 11 cases (26%).
Skyrme et al [44] retrospectively analyzed 2,215
scrotal scannings on various indications. There were
34 cases with microlithiasis (1.4%), and five had
testicular tumors (15%).
Derogee et al [45] in a similar study analyzed
1,535 scrotal ultrasound examinations and found
that 63 had microcalcifications (4%). In 29 patients
a concomitant tumor field was seen (46%), and
one patient developed a testicular tumor during
follow-up giving a total rate of 48%.
Middleton et al [46] performed a prospective
study in non-selected patients. Ultrasound was per-
formed in 1,079 men and microcalcifications were
noted in 195 (18%). A coexisting tumor was seen
in 12 patients (6%).
Pourbagher et al [47] studied ultrasound exam-
ination for scrotal pathology in 5,263 patients and
found microlithiasis in 40 (0.8%). Four patients had
a concomitant tumor (10%).
Lam et al [48] have retrospectively studied 3,254
sonographic examinations and identified 137 (4%)
patients with microlithiasis. Eight (6%) had testicular
cancer.
Ultrasound of the testes is performed on various
indications and microcalcifications will be noted 
in 1%–18%. This wide span in the prevalence
S. Lenz, A. Giwercman
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probably reflects the underlying indication for scan-
ning. When microcalcifications are noted, cancer will
be present or else develop in 6%–48%, again prob-
ably reflecting the underlying diseases (Table 2).
Follow Up of Studies of Non-selected
Men with Suspicious Echopattern
The 84 men with microlithiasis from the study by
Peterson et al [31] entered a follow-up study per-
formed by DeCastro et al [49]. Sixty-three could
be contacted after 5 years and one had developed
testicular cancer (1.6%).
We also performed a follow-up study 5 years
after having previously scanned a group of 444
non-selected men. All were cross-tabulated with
the Danish Cancer Registry. Testicular cancer was
registered in two, one in the group of very the
irregular echopatterns and one in the group assigned
a lower degree of irregularity. The original images
from the latter case were re-evaluated, and it was
seen that the echopattern was very irregular and
clearly misinterpreted at the time of scanning (Fig.
9A). The 39 men with a very irregular echopattern
were contacted and asked to participate in further
work-up. Twenty-one agreed to have a biopsy per-
formed and one showed early microinvasion. At least
three of the 39 (8%) with very irregular echopatterns
later developed testicular malignancy (Lenz, not
previously published).
Eckardstein et al [32] performed follow-up of
their group of healthy 198 volunteers 3 to 5 years
after ultrasound evaluation. One case of testis can-
cer was registered and it was in the group of six men
with microlithiasis (17%).
Table 2. Microlithiasis and testis cancer prevalence or development 
Author Year of publication
No. of men with No. of men with tumor
microlithiasis at examination or later
Backus et al [43] 1994 42 11 (26%)
Skyrme et al [44] 2000 34 5 (15%)
Derogee et al [45] 2001 63 30 (48%)
Middleton et al [46] 2002 195 12 (6%)
Pourbagher et al [47] 2005 40 4 (10%)
Lam et al [48] 2007 137 8 (6%)
A B
Fig. 9. Original scanning prints from the study of men from the general population (Lenz et al 1993) [30]. These 2 men 
later developed testicular cancer. (A) A very irregular pattern on a longitudinal scan. (B) Microlithiasis in the lower half of a 
transverse scan.
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The Diagnostic Value of Ultrasound
Screening and Additional
Recommendations
In our opinion, there is now a lot of evidence indi-
cating that ultrasound scanning is a valuable diag-
nostic tool in the detection of CIS of the testis. 
So far, there seems to be not enough evidence to
define those only with bilateral microlithiasis as
being at high risk, as proposed by Gouveia-Brazao
et al [35]. The sensitivity of detecting CIS is high
(estimated >80%), although the exact magnitude
is difficult to calculate due to the scarcity of data
on follow-up of testicular biopsies and the hetero-
geneity of groups being investigated (infertile men,
men with history of cryptorchidism, men with uni-
lateral testicular cancer, and non-selected patients).
On the other hand, the specificity of finding testic-
ular microlithiasis or a very irregular pattern in rela-
tion to the risk of malignancy is rather low since
only one in five having suspicious echo patterns will
develop cancer. The degree of microlithiasis corre-
lates with a risk of CIS, and should therefore be
described together with this evaluation to assist
clinical decision making.
We propose that all men coming for andrologi-
cal examination due to infertility problems, cryptor-
chidism, and scrotal problems should undergone
testicular ultrasound and the identification of micro-
lithiasis or a very irregular pattern should lead to
referral for testicular biopsy in order to search for
CIS. Nevertheless, large follow-up studies of men
from the general population are needed in order
to find out whether this can be recommended as 
a general screening method. 
How to Perform a Scanning of 
the Testes
Ultrasound scanning of the testes is an easy and
rapid procedure which can be a part of a routine
andrological examination or used as a screening
procedure to detect focal tumors in a patient with
an increased risk of CIS.
The man is placed in the supine position. The
penis is held upward and covered by a towel. With
the legs placed close together the scrotum is pre-
sented in a firm position for scanning. Use a near-
field probe with a frequency of 7.5–10MHz, covered
by a thin plastic bag, and place it directly at the
scrotum. Ultrasound gel should be applied inside
and outside the bag. Each side is scanned sepa-
rately. The testis is measured in three dimensions
and the scanner’s volume calculator is used to cal-
culate the volume. The normal volume for the right
testis is 14 mL, and for the left testis 13 mL. Lower
volumes always indicate impaired testicular function.
The echopattern of the testes should be evaluated,
Fig. 11. Cancer lesion  noticed as a 6 mm hypoechogenic
structure inside the testis (green arrow). The testis residue 
displays a moderate degree of microlithiasis (blue arrows).
Fig. 10. Color Doppler shows the vessels inside the testis 
radiating from the rete testis. The rete testis is marked by a
blue arrow. A bigger artery is seen outside the testis in the 
epididymis (red).
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the normal pattern being slightly irregular. A very
irregular pattern or the presence of bright echo-
genic points should be registered as an abnormal
finding. Perform a grading of these microcalcifica-
tions when seen. The rete testis is seen laterally as
an echogenic lining along the testis (Fig. 5). Vessels
are seen radiating from it and into the testicular
tissue separating the lobuli (Fig. 10). Tumors appear
hypoechogenic (Fig. 11). They can be detected from
a size of 4 mm in diameter and will be malignant
in 95% of cases [50].
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